Apricus Biosciences, Inc. 6330 Nancy Ridge Drive Category: Proprietary Drug Products
|
 |
Company representatives
Paula Schwartz, Senior VP, Investor Relations
About Apricus Biosciences, Inc.
A pharmaceutical company leveraging its NexACT drug delivery technology to enable multi-route administration of new and improved compounds.
A San Diego based revenue-generating pharmaceutical company leveraging the flexibility of its clinically-validated NexACT drug delivery technology to enable multi-route administration of new and improved compounds across numerous therapeutic classes. Revenues and growth are driven from out-licensing of this technology for the development and commercialization of such compounds to pharmaceutical and biotechnology companies worldwide. In addition, the Company is seeking to monetize its existing product pipeline, including its first product, Vitaros, approved in Canada for the treatment of erectile dysfunction, which is currently expected to be available on the Canadian market in 2011, as well as compounds in development from pre-clinical through Phase III.
Products and Services
- Pharmaceutical Products
Business categories
- Drug Manufacturers
Employees
20 to 49
Years In Business
37
Rating
Browse U.S. states for Proprietary Drug Products
